glp-1 leaky gut Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential GLP-1 and Microbiome Repair for
Description
doi: 10.1056/NEJMoa1607141 9 ArodaVR
Access and Affordability: Access and Affordability: Access and affordability challenges are a key factor preventing the GLP-1 market from reaching its peak potential, particularly in obesity where payer coverage is limited
A molecular mechanism for the effect of lithium on development
Neuroprotective Effects of a Triple GLP-1/GIP/glucagon Receptor Agonist in the APP/PS1 Transgenic Mouse Model of Alzheimers Disease
Those with NAION may have no warning before vision loss occurs while others report loss of vision that occurs over hours to days
